Maravai LifeSciences Strengthens Executive Leadership Team to Support Long-Term Growth
27 juin 2022 08h00 HE
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, June 27, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced today...
TriLink BioTechnologies, Part of Maravai LifeSciences, Announces Cooperative Agreement With Department of Defense
24 mai 2022 08h00 HE
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, May 24, 2022 (GLOBE NEWSWIRE) -- TriLink BioTechnologies (TriLink), a Maravai LifeSciences company (Maravai) (NASDAQ: MRVI), and a leader in the production of nucleic acids for research,...
Maravai LifeSciences Announces May and June 2022 Investor Conference Schedule
11 mai 2022 16h05 HE
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, May 11, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to...
Maravai LifeSciences Reports First Quarter 2022 Financial Results
05 mai 2022 16h05 HE
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, May 05, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech...
Maravai LifeSciences To Host Earnings Conference Call on Thursday, May 5, 2022
21 avr. 2022 17h01 HE
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, April 21, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators,...
Maravai LifeSciences Announces March 2022 Investor Conference Schedule
09 mars 2022 16h30 HE
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, March 09, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled...
Maravai LifeSciences Reports Fourth Quarter and Full Year 2021 Financial Results and Updates 2022 Financial Guidance
23 févr. 2022 16h05 HE
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech...
Maravai LifeSciences Acquires MyChem, a Leader in Proprietary Ultra-Pure Nucleotides
28 janv. 2022 08h00 HE
|
Maravai LifeSciences Holdings LLC
MyChem’s nucleotide synthesis methods are highly complementary to Maravai’s TriLink mRNA technologies Increases capabilities serving the high-growth cell and gene therapy market SAN DIEGO, Jan. 28,...
Maravai LifeSciences Announces Upcoming Investor Events
25 janv. 2022 17h05 HE
|
Maravai LifeSciences Holdings LLC
R&D Day - January 28, 2022 Q4 Earnings Conference Call - February 23, 2022 SAN DIEGO, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life...
Maravai LifeSciences Announces Debt Repricing
20 janv. 2022 16h05 HE
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech...